產(chǎn)品名稱 |
TeloHAEC |
商品貨號(hào) |
B211207 |
Organism |
Homo sapiens, human |
Tissue |
aorta |
Cell Type |
endothelial |
Product Format |
frozen |
Morphology |
endothelial |
Culture Properties |
adherent |
Biosafety Level |
2 [Cells containing SV40 viral DNA sequences]
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
Disease |
normal |
Age |
34 years old |
Gender |
female |
Applications |
TeloHAEC (ATCC CRL-4052) cells retain important endothelial cell characteristics such as CD31/PECAM-1 marker expression and LDL functional uptake; the cells also show effective inflammatory response upon TNFα treatment and increase proliferation upon VEGF stimulation. When co-cultured with fibroblasts, TeloHAEC cells can also form neoangiogenic tubular networks in vitro, which are responsive to VEGF stimulation and suramin inhibition. |
Storage Conditions |
liquid nitrogen vapor phase |
Karyotype |
This is a diploid cell line of female origin with a consistent normal kayrotype at low and high passages |
Images |
 |
Derivation |
TeloHAEC is a clonal cell line immortalized by stably expressing human telomerase catalytic subunit hTERT |
Clinical Data |
female
34 |
Antigen Expression |
Positive for CD31/PECAM-1 expression and capable of uptaking Low Density Lipoprotein (LDL). |
Complete Growth Medium |
The base medium for this cell line is Vascular Cell Basal Medium (ATCC PCS-100-030), supplemented with Vascular Endothelial Cell Growth Kit-VEGF (ATCC PCS-100-041). Optional: Add 0.3ug/mL Puromycin(Santa Cruz Biotech: sc-108071A). Note: Do not filter complete medium. |
Subculturing |
Volumes used in this protocol are for 75 cm2 flasks; proportionally reduce or increase amount of dissociation solutions for culture vessels of other sizes.
Subculture when the culture is about 90% confluent.
- Remove and discard spent medium.
- Briefly rinse the cells with Dulbecco's Phosphate Buffered Saline (DPBS, ATCC 30-2200) and discard rinse solution.
- Add 2.0 to 3.0 mL room temperature Trypsin-EDTA for Primary Cells (ATCC PCS-999-003) to the flask. Incubate at 37°C for 5 min (until cells have detached).
- Neutralize trypsin by adding an equal volume of room temperature 2% FBS in DPBS.
- Centrifuge cells at 250 x g for 5 min at room temperature.
- Remove supernatant. Resuspend pellet in 6.0 to 8.0 mL Complete Growth Medium.
- Count cells, and seed 5.0 x 103 to 8.0 x 103 viable cells/cm2 to new culture vessels.
Medium Renewal: Every 2-3 days. |
Cryopreservation |
90% FBS, 10% DMSO |
Culture Conditions |
Atmosphere: air, 95%; carbon dioxide (CO2), 5%
Temperature: 37°C |
STR Profile |
D5S818: 12
D13S317: 9, 12
D7S820: 10, 11
D16S539: 12, 13
vWA: 15, 16
Amelogenin: X
TPOX: 8
CSF1PO: 11, 12
TH01: 6, 8 |
Population Doubling Level (PDL) |
As part of our quality control, we have tested this cell line for its ability to grow for a minimum of 15 population doublings after recovery from cryopreservation. We have also compared its karyotype, telomerase expression level, growth rate, morphology and tissue-specific markers when first recovered from cryopreservation with that of cells at 10+ population doublings to ensure that there is no change in these parameters and that the cells are capable of extended proliferation. |
Name of Depositor |
ATCC |